New Option for Advanced HER2 Breast Cancer
HER2 is a protein that can be overexpressed in breast cancer, causing an aggressive disease. While there are treatments that target HER2, this form of cancer is tenacious. Scientists have found a new treatment option for this type of breast cancer.
HER2 Genes Not Just For Her
The HER2 gene is best known for its role in breast cancer. Having this faulty gene increases a woman’s risk of developing breast cancer. But the influence of HER2 may be far more wide-reaching.
Living Longer with HER2+ Breast Cancer
HER2-positive breast cancers are more aggressive forms of breast cancer. These tumors contain a protein that promotes cancer cell growth. HER2-positive breast cancers can also be driven by the hormone estrogen.
Targeting HER2 in Lung Cancer
You may have heard of HER2-positive breast cancer. You may not know that this gene can also play a role in lung cancer. And anti-HER2 medications may be useful in treating the world’s most common cancer.
Skipping Chemo to Treat a Breast Cancer
Aggressive breast cancer requires aggressive treatment. The therapy for one menacing type of breast cancer – HER2-positive – almost always involves chemotherapy. Maybe not for everyone, though.
Women Who Benefit Most From New HER2 Medication
In late February, the US Food and Drug Administration approved a new medication to treat HER2-positive breast cancer. The medication works by zeroing in on the HER2 proteins and then blasting them with a powerful chemotherapy agent.
Cancer Rx May Prevent Spread of Breast Cancer
Herceptin (trastuzumab) is a leading medication used to treat a particularly aggressive form of breast cancer, known as HER2-positive. Researchers are now suggesting the medicine may be useful in treating other forms of breast cancer.
New HER2+ Breast Cancer Rx Approved
Patients with HER2-positive breast cancer have a new medication to treat the disease in its late stages, after it has started to spread.
Can Resistance to HER2 Therapy Be Overcome?
The standard of care for HER2-positive breast cancer is Herceptin ( trastuzumab ). Over time, though, this aggressive cancer can become resistant to the medication. New research may have discovered a way around this resistance.
One Equals More Than Two
Herceptin is the standard medication for treating HER2-positive breast cancer. There has been some question about how long this treatment should last. A new study has answered that question.